profit from every ¥100 of sales.
¥0¥100
Organo
¥1,800.00+2.97% today
+8,839.2% in 1 year
1-year low ¥19.431-year high ¥3,679.00
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay ¥17.14 for every ¥1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Organo sold, what it kept, and what it did with the cash.
Sales went from ¥112 billion in 2022 to ¥163 billion in 2025, with ¥24.2 billion of profit last year.
SalesProfit
Organo handed back 35% of the cash it generated last year.
¥6.1B
Free cash flow 2025¥18.4B
Bought back its own shares¥330M
Paid as dividends¥6.1B
Cash vs. debt¥16.8B vs. ¥22.6B
Organo vs. similar companies
Organo grows the fastest of these 5 and is the cheapest for its profits.
| Company | Profit from ¥100 of sales | Sales growth a year | Price per ¥1 of profit |
|---|---|---|---|
| Organo | 17.1× · Fair price | ||
 Canmax Technologies | 79.6× · Very expensive | ||
 Kurita Water Industries | 28.3× · Fair price | ||
 Zijin Longking | 21.4× · Fair price | ||
 Munters Group | 235.5× · Very expensive |
AI analysis
An AI analyst reads Organo's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of JPY | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 112,069 | 132,426 | 150,356 | 163,269 | |
| 28,512 | 34,976 | 43,841 | 55,182 | |
| 10,850 | 15,213 | 22,544 | 31,121 | |
| 14,155 | 18,018 | 25,883 | 34,529 | |
| 9,210 | 11,730 | 17,310 | 24,150 | |
| 200.67 | 255.77 | 376.92 | 525.37 | |
| 25.4% | 26.4% | 29.2% | 33.8% | |
| 9.7% | 11.5% | 15.0% | 19.1% | |
| 8.2% | 8.9% | 11.5% | 14.8% |
Balance sheet
| In millions of JPY | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 130,506 | 164,854 | 182,703 | 194,396 |
| Cash | 20,198 | 15,558 | 17,642 | 16,751 |
| Total debt | 15,628 | 33,019 | 36,465 | 22,557 |
| Total liabilities | 54,502 | 78,484 | 80,557 | 73,203 |
| 75,836 | 86,169 | 101,927 | 120,947 | |
| 46 | 46 | 46 | 46 | |
| 9.8% | 9.5% | 12.1% | 15.9% | |
| 12.1% | 13.6% | 17.0% | 20.0% |
Cash flow
| In millions of JPY | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 10,787 | -18,536 | 3,726 | 21,100 | |
| 2,798 | 1,452 | 1,647 | 2,689 | |
| 7,989 | -19,988 | 2,079 | 18,411 | |
| Dividends paid | 1,541 | 2,347 | 3,405 | 6,074 |
| 354 | 4 | 2 | 330 | |
| – | – | – | – |
Valuation
- 17.1×
- –
- 0.45
- 2.9×
- 2.5×
- 22.5×
- 12.2×
- 4.4%
- 5.8%
- 1.5%
Profitability
- 33.8%
- 19.1%
- 14.8%
- –
- 15.2%
- 13.2%
- –
- –
- –
- –
Growth
- +13.4%
- +37.8%
- –
- –
- +0.1%
Financial health
- 0.1×
- 0.24
- –
- 129.6×
- 2.71
- –
- –
How it ranks in Industrials
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 12%of 982
Top 12%of 988
Top 34%of 870
Top 24%of 985
Top 40%of 988
1.5%of the share price, paid each year
On $1,000 invested$15a year at today's yield, before tax
–per share
Raised–not every year
How safe it looks
25.2% of its profit
Room to growStretchedMore than it earns: 33.0%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
4/7Passes 4 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
64Pass
Benjamin Graham
63Pass
Philip Fisher
69Pass
Peter Lynch
90Pass
Joel Greenblatt
44No pass
Charlie Munger
56No pass
Terry Smith
44No pass
Questions about Organo
Is Organo a good stock to buy?
A solid business at a fair price. 4 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Organo AI analysis
What does Organo do?
Organo Corporation operates as a water treatment engineering company in Japan, Taiwan, the United States, China, Southeast Asia, and internationally. It is in Pollution & Treatment Controls, based in Koto, Japan.
Does Organo pay a dividend?
Yes. At today's price the dividend is 1.5% a year, about 25% of its yearly profit. In 2025 it paid out ¥6.07 billion in dividends.
Is Organo stock halal?
Yes. Organo passes our halal screen: its business is permitted and its debt is 5% of its market value, under the 30% limit. How we check
How has Organo stock done over the past year?
Up 8,839.2% over the past twelve months, to ¥1,800.00. It traded between ¥19.43 and ¥3,679.00 and is 51.1% below its high.
Who are Organo's competitors?
The largest listed companies in the same industry are Canmax Technologies, Kurita Water Industries, Zijin Longking and Munters Group. The peers table on this page compares their profit, growth and price with Organo's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.